Mozavaptan
| CAS No. | 137975-06-5 | Cat. No. | BCP06718 |
| Name | Mozavaptan | ||
| Synonyms | OPC-31260; OPC31260l;OPC 31260; OPC-31260l;OPC31260; OPC 31260l; | ||
| Formula | C27H29N3O2 | M. Wt | 427.54 |
| Description | Mozavaptan, also known as OPC 31260, is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Vasopressin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.